ADA Scientific Sessions 2025 Abstract·13 JunThe Efficacy and Safety of Dapaglifrozin in Type 1 Diabetic Patients with Diabetic Kidney Disease in Zhongshan, ChinaTrial in peopleInterventionsPaper